are both facilitated by the various modifications of the combined spinal-epidural technique. [1] methods A prospective randomized double-blind controlled study was conducted on sixty patients physical status Class I and II in our hospital, who were aged between 18 and 60 years and scheduled to undergo elective surgery after hospital ethical committee approval.
Patients satisfying all the inclusion criteria (American Society of Anesthesiologists [ASA] Grade I and II status, 18-60 years of age and patients giving informed written consent) were enrolled in the study. The exclusion criteria were ASA III and above, age more than 60 years and <18 years, pregnant and lactating women, uncooperative patients, hypotension, previous spinal surgeries, spine abnormalities, local site infection and coagulation abnormalities, poorly controlled hypertension, angina, and cardiopulmonary disease, hematological disease, neurologic, psychiatric disease, severe renal or hepatic derangement, patients taking tricyclic antidepressants, any antipsychotic drugs, α2 adrenergic agonists, opioids, antiarrhythmic agents, beta-blockers, and anticoagulants.
Patients were randomly allocated into two groups of thirty each.
• Group A (n = 30) = Patients receiving 0.5% isobaric levobupivacaine 15 mg (3 ml) intrathecally and clonidine 2 μg/kg in 10 ml 0.9% normal saline epidurally • Group B (n = 30) = Patients receiving 0.5% isobaric levobupivacaine 15 mg (3 ml) intrathecally and dexmedetomidine 1.5 μg/kg in 10 ml 0.9% normal saline epidurally.
Identical syringes containing each drug were prepared by one of the anesthesiologists who did not participate in the study. Patient and anesthesiologist who would deliver the combined spinal-epidural anesthesia were blinded by the study solutions. All preanesthetic evaluation of all patients was performed by an anesthesiologist a day before the surgery. In operation theater, a peripheral intravenous access was secured using 18G cannula and ASA standard monitors were attached-non-invasive blood pressure (BP), electrocardiograph, pulse rate, and SPO 2 were recorded. As a standard premedication, injection Metoclopramide 10 mg intravenous was given. All patients were preloaded with Ringer lactate solution 20 ml/kg before the block. Intravenous fluids were given as per body weight intraoperatively and operative loss requirement.
The patient was put in sitting position under aseptic precautions, epidural space of L2-L3 interspaces was located, and with the 18-gauge Tuohy needle, using midline approach and loss of resistance technique, an epidural catheter of 18-gauge was placed in epidural space. A test dose of 3 ml of lignocaine with adrenaline 1:200,000 was administered to exclude intrathecal or intravascular placement of the needle.
Using 24-26-gauge Quincke spinal needle, subarachnoid block was performed at L3 L4 interspace and 3 ml of 0.5% isobaric levobupivacaine was administered to both groups. Intraoperative block characteristics such as time taken for motor block, time taken to reach T 10 dermatome, and maximum level of block were recorded.
After 20 min of administering intrathecal levobupivacaine, patients in Group A received clonidine 2 μg/kg body weight in 10 ml 0.9% normal saline and Group B received dexmedetomidine 1.5 μg/kg body weight in 10 ml 0.9% normal saline epidurally.
Cardiorespiratory parameters were monitored continuously, and recordings made every 5 min until 30 min and every 10 min until 60 min and then every 15 min for the next hour and finally at 30 min till the end of surgery.
Intra-and post-operatively, the incidence of bradycardia (heart rate <50 beats/min) will be treated with 0.6 mg of injection atropine, and hypotension (systolic BP falling more than 20% mm of Hg) will be treated with injection mephentermine 6 mg in bolus.
Sedation scores were recorded just before the initiation of surgery and every 30 min.
Ramsay sedation scale was used to assess the level of sedation.
[5]
• 1 -Anxious and agitated During surgical procedure, adverse effects such as anxiety, nausea, vomiting, dry mouth, dizziness, headache, respiratory depression, pruritus, and shivering will be recorded.
Duration of analgesia will be recorded as time interval from the completion of anesthesia to the time when the patient complains of pain. Postoperatively, patients will be assessed at 30 min, 2 h, 6 h, and 24 h for postoperative analgesia. The intensity of postoperative pain will be assessed using visual analog scale (VAS), 0 is no pain and 10 is maximum pain. Rescue analgesia will be provided by intramuscular injection of tramadol 75 mg, when patient complains of pain or VAS of >4. [6] statIstIcal analysIs
Sample size was based on the previous studies, with 21 minimum in each group and with α error of 1%, beta error of 10%, confidence interval of 99%, and power of the study was 90%.
A commercial software package -SPSS version 19, was used for statistical analysis. Perioperative data on various parameters in Group A and Group B were expressed in the tables as mean ± standard deviation.
The parametric data were statistically analyzed using the paired t-test for comparison of within-group data, and the unpaired t-test for comparison of between-group data.
Mann-Whitney U-test was used to analyze nonparametric data.
P value was considered statistically significant if <0.05.
results
The patients in the two groups were comparable with regard to age, sex, weight, height, ASA grading, and duration of surgery [ Table 1 ].
As shown in Table 2 , there was no statistical difference between two groups with respect to mean time taken for loss of pinprick sensation at T10 and mean time taken to achieve modified Bromage grading of motor block 3 as both groups received intrathecal levobupivacaine.
As shown in Graphs 1 and 2, a statistically significant fall in the pulse rate and mean arterial pressure (MAP) was noticed 20 ± 5 min following epidural clonidine and dexmedetomidine injection in both groups and persisted for all time intervals thereafter, until the end of the study period. However, the pulse rate and MAP remained in the normal physiological range throughout the study period.
Patients in both groups were sedated after 20 ± 5 min following epidural drug administration. Sedation scores were higher following the administration of dexmedetomidine in the epidural space compared to epidural clonidine and sedation lasted for 45 ± 5 min [Graph 3].
As shown in Table 3 , there was a significant prolongation of the mean time taken for sensory regression to S1 in Group A, 350.87 min and Group B, 367.37 min, with P value of 0.0001. There was a significant prolongation of the mean time taken to regression to Bromage 0 in Group A 306.17 min and Group B 325 min with P = 0.00001.
In our results, we found that during initial 270 min, i.e., from baseline to 270 min, P value being >0.05, it was statistically insignificant. The difference in VAS scores of two Groups A and B becomes statistically significant at 300-450 min time intervals with P < 0.05.
VAS score was higher in clonidine group requiring rescue analgesia at 300 min and maximum VAS scores at 360-390 min, whereas in dexmedetomidine group VAS score started to increase only after 390 min and maximum 
dIscussIon
The CSE technique has gained increasing importance for patients undergoing below the umbilical level surgery who require effective and prolonged postoperative analgesia. CSE anesthesia combines the density, rapidity, and reliability of a subarachnoid anesthetic with added advantage of the flexibility of continuous epidural anesthesia to extend the duration of analgesia. [1] Levobupivacaine, the S-enantiomer of bupivacaine has significantly less cardiac and neural toxic effects than bupivacaine, while still possessing a similar duration of sensory blockade. Levobupivacaine has been shown to be safe and effective for epidural and spinal anesthesia. [7] [8] [9] Epidural administrations of α2 agonists are being used as adjuvants as they lead to anxiolysis, sedation, analgesia, and hypnosis. The pharmacological actions are extensively studied as these agents can be used instead of opioids which are known to cause many side effects such as nausea, vomiting, pruritus, and urinary retention. [10] The anesthetic and the analgesic requirement get reduced to a large extent by the use of α2 agonists because of their analgesic properties and augmentation of local anesthetic effects as they cause hyperpolarization of nerve tissues by altering transmembrane potential and ion conductance at locus coeruleus in the brainstem. [11] Sedation is due to action on locus coeruleus, which inhibit the release of norepinephrine. [12, 13] Sedation after epidural α2 agonists is due to its systemic absorption and vascular redistribution to higher centers. [14] [15] [16] Sedation is an add-on advantage for regional anesthesia to bring down the stress associated with the surgery.
Dexmedetomidine is a highly selective α2 adrenergic agonist with an affinity of 8 times greater than clonidine and hence allows the use of higher doses with less α1 effect. There is no such study which has compared the dose equivalence of these drugs, but the observations of various studies have stated that the dose of clonidine is 1.5−2 times higher than dexmedetomidine when used in epidural route. [11] Neuraxial clonidine enhances the action of local anesthetics, increases the intensity and duration of analgesia. It is known to have sedative properties, and the side effects are hypotension and bradycardia. [17] A study conducted by Jain et al. [18] showed similar results to our study with fall in pulse rate and BP 5-10 min following administration of epidural dexmedetomidine. There was statistically significant fall in pulse rate in dexmedetomidine group compared to saline group, at all time intervals. They also had higher sedation scores in dexmedetomidine group and also prolonged sensory and motor blockade with a reduced dose of rescue analgesia.
Fukushima et al. were the first to report the use of epidural dexmedetomidine in patients undergoing surgery under general anesthesia. They found that after 10 min of epidural injection of 2 μg/kg dexmedetomidine resulted in decreased heart rate and BP, which was correlating with our study. [19] Salgado et al. studied the synergistic effect of dexmedetomidine with 0.75% ropivacaine and observed that epidural dexmedetomidine 1 μg/kg enhances motor and sensory blockade, and prolongs analgesia duration. [20] The analgesic effect of dexmedetomidine is produced by the stimulation of the α2 receptors at spinal cord level. At the dorsal root neuron, α2 agonists inhibit the nociceptive pathway by releasing substance P and by inhibiting the release of norepinephrine, which may have a possible role in analgesia. Even with the evidence of both the supraspinal and peripheral sites of action of dexmedetomidine, the spinal mechanism may be mainly responsible for the analgesic effects. [21, 22] In a study done by Bajwa et al., time for rescue analgesia was comparatively lesser (310.76 ± 23.75 min) in the patients who were administered clonidine (P < 0.05) when compared to dexmedetomidine (342.88 ± 21.86 min) which was similar to our study. [11] Graph 4: Visual analog scale scores of two Group A and B at different time intervals. (P < 0.05 is statistically significant) Summary of our study is that dexmedetomidine administered epidurally had superior and prolonged analgesia with superior anesthetic effects with respect to the duration of sensory blockade, and motor blockade compared to epidural clonidine. Epidural dexmedetomidine also had higher sedation scores compared to clonidine.
Limitation of our study is that we had no placebo group and further scope will be to design the study with different doses of α2 agonists.
conclusIon
Epidural dexmedetomidine in a dose of 1.5 μg/kg with intrathecal levobupivacaine causes significant prolongation in the duration of analgesia and thus decreasing the need for additional analgesic agents.
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